α-Ketoglutarate links p53 to cell fate during tumour suppression-Reference-Cited by-同舟云学术

α-Ketoglutarate links p53 to cell fate during tumour suppression

Published:2019-09-18 Issue:7775 Volume:573 Page:595-599
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Morris John P.,Yashinskie Jossie J.,Koche Richard,Chandwani Rohit,Tian Sha,Chen Chi-Chao,Baslan Timour,Marinkovic Zoran S.,Sánchez-Rivera Francisco J.,Leach Steven D.,Carmona-Fontaine Carlos,Thompson Craig B.,Finley Lydia W. S.,Lowe Scott W.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1577-5.pdf

Reference61 articles.

1. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015).

2. Kastenhuber, E. R. & Lowe, S. W. Putting p53 in context. Cell 170, 1062–1078 (2017).

3. Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393–405 (2015).

4. Morris, J. P. IV, Wang, S. C. & Hebrok, M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer 10, 683–695 (2010).

5. Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47–52 (2016).

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance;International Journal of Molecular Sciences;2024-08-21

2. Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation;Signal Transduction and Targeted Therapy;2024-08-15

3. Aristolochic acids-hijacked p53 promotes liver cancer cell growth by inhibiting ferroptosis;Acta Pharmacologica Sinica;2024-08-01

4. Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations;Bioorganic Chemistry;2024-08

5. Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer;Cell Reports;2024-07